Skip to main content

Advertisement

Table 2 Effect of pyridoxine on the fatty acid composition in erythrocyte membranes

From: Variations in the lipid profile of patients with chronic renal failure treated with pyridoxine

   Days of treatment  
Fatty acid Basal 1 30 60 Basal 2
16:0 22.0 ± 1.0a 19.0 ± 1.3a 17.0 ± 1.4b 23.8 ± 0.9a
16:1 0.3 ± 0.05a 1.0 ± 0.2b 1.0 ± 0.1b 1.3 ± 0.2b
18:0 20.4 ± 0.3a 22.0 ± 0.5b 23.0 ± 0.4b 19.3 ± 0.2c
18:1 14.7 ± 0.4 14.3 ± 0.5 14.7 ± 1.3 14.2 ± 0.6
18:2 n-6 10.7 ± 0.4 11.0 ± 0.5 10.5 ± 1.0 10.6 ± 0.5
20:3 n-6 1.9 ± 0.1 1.6 ± 0.1 2.1 ± 0.2 1.6 ± 0.1
20:4 n-6 19.4 ± 0.9a 19.0 ± 0.7a 20.6 ± 0.7a 15.7 ± 0.7b
22:4 n-6 0.5 ± 0.1a 0.4 ± 0.05a 0.5 ± 0.1a 0.2 ± 0.02b
22:5 n-6 4.7 ± 0.5 4.1 ± 0.3 4.7 ± 0.3 3.5 ± 0.2
22:5 n-3 2.6 ± 0.2a 2.3 ± 0.2ab 2.6 ± 0.2a 1.9 ± 0.1b
22:6 n-3 4.7 ± 0.3 5.6 ± 0.5 5.0 ± 0.5 4.2 ± 0.3
  1. Results are the means of 12 determinations ± 1 SEM expressed as μg % of total fatty acids. Fatty acids are identified by: number of carbon atoms in the chain is given first, value following the colon represents number of double bonds (zero means saturated fatty acid); number following n- indicates the position of the last double bond counting the double bond from the terminal methyl group. Values not bearing the same superscript letter are significantly different at P < 0.05.